Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

K. Sarnow; S. G. Schwab; O. Rio; J. Mukherjee; R. Bjerkvig; T. A. Johannessen

doi:10.1093/neuonc/noab180.195

Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

K. Sarnow
, S. G. Schwab
, O. Rio
, J. Mukherjee
, R. Bjerkvig
, T. A. Johannessen

Department of Cancer Research

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	P15.02
Pages (from-to)	56-56
Journal	Neuro-Oncology
Volume	23
Issue number	Suppl.2
DOIs	https://doi.org/10.1093/neuonc/noab180.195
Publication status	Published - Sept 2021
Event	16th Meeting of the European Association of Neuroncology (EANO) Virtual congress - Duration: 25 Sept 2021 → 26 Sept 2021

Access to Document

10.1093/neuonc/noab180.195

Cite this

@article{71c84355ea7e4896a694c5681d796077,

title = "Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression",

author = "K. Sarnow and Schwab, \{S. G.\} and O. Rio and J. Mukherjee and R. Bjerkvig and Johannessen, \{T. A.\}",

year = "2021",

month = sep,

doi = "10.1093/neuonc/noab180.195",

language = "English",

volume = "23",

pages = "56--56",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Suppl.2",

note = "16th Meeting of the European Association of Neuroncology (EANO) Virtual congress ; Conference date: 25-09-2021 Through 26-09-2021",

}

TY - JOUR

T1 - Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

AU - Sarnow, K.

AU - Schwab, S. G.

AU - Rio, O.

AU - Mukherjee, J.

AU - Bjerkvig, R.

AU - Johannessen, T. A.

PY - 2021/9

Y1 - 2021/9

U2 - 10.1093/neuonc/noab180.195

DO - 10.1093/neuonc/noab180.195

M3 - Meeting Abstract

SN - 1522-8517

VL - 23

SP - 56

EP - 56

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Suppl.2

M1 - P15.02

T2 - 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress

Y2 - 25 September 2021 through 26 September 2021

ER -